2026-04-26T23:29:39Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/187142024-09-21T22:10:48Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16927
Repisalud
author
Sanz-Cánovas, Jaime
author
López-Sampalo, Almudena
author
Cobos-Palacios, Lidia
author
Ricci, Michele
author
Hernández-Negrín, Halbert
author
Mancebo-Sevilla, Juan José
author
Álvarez-Recio, Elena
author
López-Carmona, María Dolores
author
Pérez-Belmonte, Luis Miguel
author
Gómez-Huelgas, Ricardo
author
Bernal-López, Maria Rosa
2024-02-27T15:09:56Z
2024-02-27T15:09:56Z
2022-07-16
http://hdl.handle.net/10668/21084
http://hdl.handle.net/20.500.12105/18714
35886528
10.3390/ijerph19148677
1660-4601
International journal of environmental research and public health
The life expectancy of the population is increasing worldwide due to improvements in the prevention, diagnosis, and treatment of diseases. This favors a higher prevalence of type 2 diabetes mellitus (T2DM) in the elderly. Sarcopenia and frailty are also frequently present in aging. These three entities share common mechanisms such as insulin resistance, chronic inflammation, and mitochondrial dysfunction. The coexistence of these situations worsens the prognosis of elderly patients. In this paper, we review the main measures for the prevention and management of sarcopenia and/or frailty in elderly patients with T2DM.
eng
Elderly
Frailty
Sarcopenia
Type 2 diabetes mellitus
Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia.
research article